Cinctive Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History
Cinctive Capital Management LP
- $1.78 Billion
- Q2 2025
A detailed history of Cinctive Capital Management LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 22,868 shares of ALNY stock, worth $11.2 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
22,868
Previous 24,862
8.02%
Holding current value
$11.2 Million
Previous $6.71 Million
11.08%
% of portfolio
0.42%
Previous 0.55%
Shares
9 transactions
Others Institutions Holding ALNY
# of Institutions
769Shares Held
115MCall Options Held
584KPut Options Held
661K-
Capital World Investors Los Angeles, CA16.8MShares$8.25 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$6.53 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.69 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.53 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$2.1 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $60.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...